文献速递糖尿病

麸质摄入与胰岛自身免疫及1型糖尿病进展风险:DAISY研究

Gluten Intake and Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in Children at Increased Risk of the Disease: The Diabetes Autoimmunity Study in the Young (DAISY).
PubMed 文献 · Diabetes Care · 2019-02-22

DAISY队列随访1,916名1型糖尿病高风险儿童,发现1-2岁及随访期间麸质摄入量与胰岛自身免疫发生无关联(aHR分别为1.00和1.01)。麸质摄入与从自身免疫进展为1型糖尿病也无显著关联,但<4月龄引入麸质与进展风险升高相关(aHR 8.69)。

要点

  • 高风险儿童麸质摄入量不增加胰岛自身免疫或1型糖尿病进展风险。
  • <4月龄引入麸质与自身免疫进展为1型糖尿病风险显著升高相关。
  • 无强烈依据通过减少麸质摄入预防高风险儿童1型糖尿病。

核心结论

  • 麸质摄入量与胰岛自身免疫发生及进展为1型糖尿病无显著关联。
  • 4月龄前引入麸质与从胰岛自身免疫进展为1型糖尿病风险升高相关。

研究设计与样本

  • DAISY前瞻性队列研究,纳入1型糖尿病高风险儿童,随访至2017年8月。
  • 共纳入1,916名受试者,随访结束时中位年龄13.5岁。
  • 使用食物频率问卷每年评估1岁起麸质摄入量(克/天)。
  • 采用Cox回归和联合模型估计校正混杂因素的风险比(aHR)。

主要发现

  • 178名参与者发生胰岛自身免疫,其中56名进展为1型糖尿病。
  • 1-2岁麸质摄入每增加4克/天,胰岛自身免疫aHR为1.00(95%CI 0.85-1.17)。
  • 随访期间累积麸质摄入每增加4克/天,胰岛自身免疫aHR为1.01(95%CI 0.99-1.02)。
  • 麸质摄入与从胰岛自身免疫进展为1型糖尿病无显著关联。
  • <4月龄引入麸质 vs 4-5.9月龄,进展为1型糖尿病aHR为8.69(95%CI 1.69-44.8)。

临床怎么用

  • 不建议仅通过减少麸质摄入来预防高风险儿童1型糖尿病。
  • 应避免在4月龄前引入麸质,以降低自身免疫进展风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the association of gluten intake with development of islet autoimmunity and progression to type 1 diabetes. RESEARCH DESIGN AND METHODS: The Diabetes Autoimmunity Study in the Young (DAISY) follows children with an increased risk of type 1 diabetes. Blood samples were collected at 9, 15, and 24 months of age, and annually thereafter. Islet autoimmunity was defined by the appearance of at least one autoantibody against insulin, IA2, GAD, or ZnT8 (zinc transporter 8) in at least two consecutive blood samples. Using food frequency questionnaires, we estimated the gluten intake (in grams per day) annually from 1 year of age. Cox regression modeling early gluten intake, and joint modeling of the cumulative gluten intake during follow-up, were used to estimate hazard ratios adjusted for confounders (aHR). RESULTS: By August 2017, 1,916 subjects were included (median age at end of follow-up 13.5 years), islet autoimmunity had developed in 178 participants, and 56 of these progressed to type 1 diabetes. We found no association between islet autoimmunity and gluten intake at 1-2 years of age or during follow-up (aHR per 4 g/day increase in gluten intake 1.00, 95% CI 0.85-1.17 and 1.01, 0.99-1.02, respectively). We found similar null results for progression from islet autoimmunity to type 1 diabetes. Introduction of gluten at <4 months of age was associated with an increased risk of progressing from islet autoimmunity to type 1 diabetes compared with introduction at 4-5.9 months (aHR 8.69, 95% CI 1.69-44.8). CONCLUSIONS: Our findings indicate no strong rationale to reduce the amount of gluten in high-risk children to prevent development of type 1 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Lund-Blix NA, Dong F, Mårild K, et al. Gluten Intake and Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in Children at Increased Risk of the Disease: The Diabetes Autoimmunity Study in the Young (DAISY). Diabetes Care. 2019. PMID: 30796108. doi:10.2337/dc18-2315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。